Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#129 Grade according to Ki-67 or mitotic count in gastroenteropancreatic neuroendocrine tumors

Introduction: Gastroenteropancreatic neuroendocrine tumors (NETs) are uncommon tumors with a reported incidence of 2.5-5 per 100000 population. The recent classification system of NETs proposed by the European Neuroendocrine Tumor Society (ENETS) uses both Ki-67 labelling index and mitotic index to assign grade (low, intermediate, high). It has been adopted into routine practice but there is limited data on the relationship between these indices and their effect on classification.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author: Khan M

Authors: Khan M, Toumpanakis C, Jamieson A, Chilkunda D, Watkin J,

Keywords: neuroendocrine tumor, grade, Ki-67, mitoses ,

#124 Management and outcomes of malignant paragangliomas and phaeochromocytomas

Introduction: Chromaffin-cell tumors include phaeochromocytomas and paragangliomas, represent a rare group of neuroendocrine tumors and are located in adrenal medulla or extra-adrenal sites, respectively. Ten percent of phaeochromocytomas and 15-35% of paragangliomas are malignant.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author: TOUMPANAKIS C

Authors: Warner B, Chilkunda D, Khan M, Buscombe J, Caplin M,

Keywords: paragangliomas, phaeochromocytomas, chromaffin-cell tumours,

#39 Specialist dietetic input and nutritional outcomes in Neuroendocrine Tumour Patients

Introduction: Neuroendocrine tumors (NETs) are a heterogeneous group of tumors that are complex to manage and require a multidisciplinary approach. The most common primary sites are the small intestine and pancreas. The disease itself, as well as sequelae from surgery and medical therapy, can have a negative impact on patients’ nutritional status. Weight loss is known to be a poor prognostic indicator.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Schnaid C, Khan M, Davies P, Jamieson A, Chilkunda D,

Keywords: neuroendocrine tumor, nutrition, diet, dietitian ,